T2DM patients have low levels of physical activity: role of obesity

被引:1
|
作者
Fagour, C. [1 ]
Pezzino, S. [2 ]
Florenty, S. [2 ]
Gonzalez, C. [2 ]
Rosette-Narece, M. [1 ]
Gin, H. [2 ]
Rigalleau, V. [2 ]
机构
[1] CHU Ft France, Fort De France, Martinique, France
[2] CHU Bordeaux, Pessac, France
关键词
D O I
10.1016/S1262-3636(11)70586-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A25 / A26
页数:2
相关论文
共 50 条
  • [31] The dual role of empagliflozin: Cardio renal protection in T2DM patients
    Shafiq, Aimen
    Mahboob, Eman
    Samad, Muhammad Ammar
    Rehman, Mohammad Hassam Ur
    Tharwani, Zoaib Habib
    ANNALS OF MEDICINE AND SURGERY, 2022, 81
  • [32] Lipoprotein(a) Levels Are Twice as High in Left-Handed T2DM Patients
    Hermans, Michel P.
    Ahn, Sylvie A.
    Rousseau, Michel F.
    DIABETES, 2018, 67
  • [33] In obesity with T2DM, biliopancreatic diversion increased T2DM remission vs. medical and lifestyle therapy at 10 y
    Sarma, Shohinee
    Lipscombe, Lorraine L.
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (06) : JC70 - JC70
  • [34] Oxidative stress parameters and keap 1 variants in T2DM: Association with T2DM, diabetic neuropathy, diabetic retinopathy, and obesity
    Khalili, Farnaz
    Vaisi-Raygani, Asad
    Shakiba, Ebrahim
    Kohsari, Maryam
    Dehbani, Maryam
    Naseri, Rozita
    Asadi, Soheila
    Rahimi, Ziba
    Rahimi, Mehrali
    Rahimi, Zohreh
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (01)
  • [35] OBESITY, T2DM, METABOLIC SYNDROME INFLUENCE MORTALITY IN NAFLD IN A COHORT OF MEXICAN PATIENTS
    Perez-Arredondo, L. A.
    Cordero-Perez, P.
    Alarcon-Galvan, G.
    Martinez-Macias, R. F.
    Silvera-Linares, A.
    Munoz-Espinosa, L. E.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S736 - S736
  • [36] PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD
    Gross, Barbara
    Pawlak, Michal
    Lefebvre, Philippe
    Staels, Bart
    NATURE REVIEWS ENDOCRINOLOGY, 2017, 13 (01) : 36 - 49
  • [38] Association of Zinc Intake with Obesity in Japanese Patients with Type 2 Diabetes Mellitus (T2DM)
    Nedachi, Rina
    Fujihara, Kazuya
    Hatta, Mariko
    Matsubayashi, Yasuhiro
    Takeda, Yasunaga
    Ishii, Dai
    Horikawa, Chika
    Kato, Noriko
    Maegawa, Hiroshi
    Sone, Hirohito
    DIABETES, 2019, 68
  • [39] Emerging combinatorial hormone therapies for the treatment of obesity and T2DM
    Sharon A. Sadry
    Daniel J. Drucker
    Nature Reviews Endocrinology, 2013, 9 : 425 - 433
  • [40] PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD
    Barbara Gross
    Michal Pawlak
    Philippe Lefebvre
    Bart Staels
    Nature Reviews Endocrinology, 2017, 13 : 36 - 49